植物固醇 Phytosterols × 心血管疾病
結論：證據分歧
本層評估的主張為「植物固醇能降低心血管疾病（硬性終點：心肌梗塞、中風、心血管死亡、MACE）風險」，這與『降 LDL』是不同範疇的主張。
C 🟠 C 薄弱證據 證據分歧 🚨 high — heavy affiliate marketing in TW community
本層評估的主張為「植物固醇能降低心血管疾病（硬性終點：心肌梗塞、中風、心血管死亡、MACE）風險」，這與『降 LDL』是不同範疇的主張。
就硬性終點而言，至今沒有任何以 MACE／死亡為主要結果且具足夠檢力的隨機對照試驗（PMID 34468867 明言「no prospective, placebo-controlled, randomized trial」）。
Examine 對 CVD 條目下唯一可對應的只有血壓與 CRP 兩個替代指標（B 級），無任何臨床終點。
監管與學會層面對「硬性終點」一致採保留或否定：ACC/AHA 2013/2026 指引明言「no ASCVD outcomes identified」、未給予建議等級；NICE NG238 更明確「do not advise」植物固醇用於 CVD 預防。
更關鍵的是兩項孟德爾隨機化研究（PMID 35013273、37270173）顯示遺傳性高血清 sitosterol 與冠狀動脈粥樣硬化（OR 1.52）及心肌梗塞（OR 1.40）風險「上升」，指向可能有害的反方向訊號。
心血管硬性結局的證據因此屬薄弱（C）：機轉合理且 LDL 替代指標明確改善，但缺乏硬終點 RCT，且存在指引否定與遺傳學潛在傷害訊號。
注意：此 C 級僅針對『硬性心血管結局』主張；若主張僅限『降 LDL』，則為另一條目（COND-cholesterol），證據強得多（Examine B/A、FDA/EFSA 已核可健康宣稱）。
⚖️
評分透明度
所有分數由 7 層證據引擎計算，過程公開可查原始分數 0.49
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
C · 證據分歧
信心度
68%
證據方向大致一致
證據層級
E2
多篇高品質統合分析（≥2 篇一致）
▸查看完整決策路徑（audit trail）
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.493
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 高品質 SR/MA 顯示 positive (1 篇 > 0 negative)
- tier_strict_requirement_check — Tier 條件達標，未降階
- detect_disputes — 偵測到 1 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status
Genome-wide meta-analysis of phytosterols reveals five novel loci and a detrimental effect on coronary atherosclerosis
結論：This genome-wide meta-analysis (up to 9,758 subjects, 32 phytosterol traits) plus Mendelian randomization found a risk-INCREASING causal effect of higher plasma sitosterol on CAD (total causal estimate 0.308, SE 0.065, p=1.9x10^-6). A direct effect of sitosterol itself accounted for 53% of the total effect (0.163, SE 0.072, p=0.023), with the remainder mediated by cholesterol (0.145, SE 0.031, p=2.2x10^-6) — suggesting plant sterols per se may be atherogenic, not protective.
前往 PubMed
Blood phytosterols in relation to cardiovascular diseases and mediating effects of blood lipids and hematological traits: a Mendelian randomization analysis
結論：Mendelian randomization found that a one-unit increment in log-transformed blood total sitosterol was significantly associated with higher risk of coronary atherosclerosis (OR 1.52; 95% CI 1.41-1.65; n=667,551) and myocardial infarction (OR 1.40; 95% CI 1.25-1.56; n=596,436). Blood non-HDL-C and apolipoprotein B mediated roughly 38-60% of these associations, indicating elevated serum phytosterols are linked to greater CVD risk.
前往 PubMed
Effects of phytosterols on cardiovascular risk factors: A systematic review and meta-analysis of randomized controlled trials
結論：This meta-analysis of 109 RCTs found phytosterols significantly lowered LDL-C (mean difference -12.57 mg/dL; 95% CI -13.87 to -11.26; p<0.001), total cholesterol (-13.41) and triglycerides (-6.34), and slightly raised HDL-C (+0.46). Critically, only surrogate risk factors were assessed — hard cardiovascular events (MACE, MI, mortality) were NOT evaluated, so LDL lowering cannot be equated with proven CV benefit.
前往 PubMed
Plant sterols and cardiovascular disease: a systematic review and meta-analysis
結論：This meta-analysis of 17 observational studies (11,182 participants; case-control, cohort, cross-sectional and nested case-control) found NO association between serum plant sterol levels and CVD risk: campesterol RR 1.02 (95% CI 0.94-1.09, p=0.675) and sitosterol/cholesterol ratio RR 0.94 (95% CI 0.68-1.31, p=0.730). This contrasts with later Mendelian randomization data and is industry-funded, underscoring the unsettled outcome picture.
前往 PubMed
Phytosterols and Cardiovascular Disease
結論：This review concludes phytosterols lower LDL-C by 10-15%, but states there is no prospective, placebo-controlled, randomized trial addressing the impact of phytosterol supplementation on hard cardiovascular outcomes. It notes recent genetic evidence suggesting plant sterols per se are atherogenic, with non-HDL cholesterol explaining only ~60% of the associated CVD risk increase, and explicitly calls for RCTs with hard CV outcomes before any general recommendation.
前往 PubMed
L4a US FDA
支持
Foods containing at least 0.65 g per serving of plant sterol esters, eaten twice a day with meals for a daily total intake of at least 1.3 g, as part of a diet low in saturated fat and cholesterol, may reduce the risk of heart disease. 來源↗
L4b EU EFSA
支持
L4c UK NHS
反對
Do not advise any of the following to take plant stanols or sterols to prevent CVD: people being treated for primary prevention; people being treated for secondary prevention; people with CKD; people with type 1 diabetes; people with type 2 diabetes. [2014] 來源↗
L4d TW TFDA / 衛福部
支持
市售有兩款添加植醇的植物油（透過衛福部審核通過之健康食品資料庫）。每日攝取2到3克的植物固醇，對於降低血中的總膽固醇與低密度脂蛋白膽固醇（壞的膽固醇）都有顯著的幫助。 來源↗
L4e WHO
中性
JECFA established a group acceptable daily intake (ADI) of 0-40 mg/kg body weight for phytosterols, phytostanols and their esters, expressed as the sum of phytosterols and phytostanols in their free form, based on an overall NOAEL of 4200 mg/kg bw per day to which a safety factor of 100 was applied. 來源↗
L5a NIH Office of Dietary Supplements
謹慎
L5b Mayo Clinic
中性
Adding 2 grams of sterol to your diet every day can lower your LDL cholesterol by 5% to 15%. However, it's not clear whether food with plant sterols or stanols lowers your risk of heart attack or stroke — although experts assume that foods that lower cholesterol do cut the risk. 來源↗
L5c Cleveland Clinic
支持
L5d Harvard Health
謹慎
L5e Specialty Society (condition-mapped)
中性
PTT · Dcard · Mobile01 彙整自公開論壇討論，非統計抽樣，僅反映社群風向。
廣告 / 業配密度 極高
低中高
📍立場總覽
台灣社群（PTT FITNESS／regimen、Dcard、Mobile01）討論「降膽固醇／心血管保健」時，焦點幾乎全在紅麴、納豆激酶、魚油 Omega-3、苦瓜胜肽與飲食運動（少糖少油、好油、植物性蛋白），鮮少有人單獨討論「植物固醇 / 植物甾醇 / β-穀固醇」並分享實測心得。植物固醇主要出現在保健品『降血脂排行榜』『推薦』類業配文與康健等媒體科普中，社群原生使用經驗極少，屬冷門成分；現有討論多為『每天2克可降壞膽固醇約10%』的衛教複述，而非鄉民親身體感。
💬社群實感
無共識（台灣社群幾乎不單獨討論植物固醇用於降膽固醇／心血管，缺乏鄉民親身實測心得；相關保健話題的實測分享集中在紅麴、納豆激酶、魚油與苦瓜胜肽，而非植物固醇本身）
破解迷思 社群最常見的 4 個誤解
✓
事實誤以為多吃堅果、植物油等天然食物即可攝足植物固醇來降膽固醇（實際天然食物含量極微，需每日約2克強化食品或補充劑才達有效劑量）
✓
事實把植物固醇與紅麴／納豆激酶等其他降血脂保健成分混為一談，誤以為功效與機轉相同（植物固醇是抑制腸道膽固醇吸收，紅麴 Monacolin K 是抑制合成）
✓
事實誤以為植物固醇等保健品可取代 statin 等藥物或省去就醫（社群與醫師多強調保健品降幅有限、僅為輔助，膽固醇約7成為肝臟自行合成）
✓
事實誤以為植物固醇『多吃多降』、效果與劑量無上限（過量並不會等比例增加降膽固醇效果，且高吸收體質者另有植物固醇血症 sitosterolemia 風險）
- 生活型態優化（健康飲食、身體活動、戒菸）
- 史他汀類藥物（適應症族群）
- 戒菸（行為介入合併藥物）
查看 ClaimReview 結構化資料 (JSON-LD)
{
"@context": "https://schema.org",
"@type": "ClaimReview",
"url": "https://gpt-dict.com/claim/CLM-COND-cardiovascular-disease-INT-phytosterols-001/",
"datePublished": "2026-06-01",
"author": {
"@type": "Organization",
"name": "gpt-dict.com",
"url": "https://gpt-dict.com"
},
"claimReviewed": "植物固醇能改善心血管疾病",
"inLanguage": "zh-TW",
"itemReviewed": {
"@type": "Claim",
"appearance": []
},
"reviewRating": {
"@type": "Rating",
"ratingValue": 2,
"bestRating": 5,
"worstRating": 1,
"alternateName": "🟠 C 薄弱證據"
}
}